Adam Morgan is a director of Heron Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
BALAJI VENKATARAMAN
9 Feb 24
4
HERON THERAPEUTICS, INC. /DE/
19 Jan 24
4
BALAJI VENKATARAMAN
4 Oct 23
4
BALAJI VENKATARAMAN
17 Aug 23
4
HERON THERAPEUTICS, INC. /DE/
25 Jul 23
4
ALIMERA SCIENCES INC
19 May 23
4
ALIMERA SCIENCES INC
28 Mar 23
3
ALIMERA SCIENCES INC
28 Mar 23
4
HERON THERAPEUTICS, INC. /DE/
24 Feb 23
3
HERON THERAPEUTICS, INC. /DE/
8 Feb 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Feb 24 | JSPR Jasper Therapeutics | Common Stock, par value $0.0001 per share | Buy | Acquire P | Yes | No | 12.95 | 350,000 | 4.53 mm | 1,188,500 |
19 Jan 24 | HRTX Heron Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 13,948 | 0.00 | 51,827 |
19 Jan 24 | HRTX Heron Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.09 | 83,685 | 174.90 k | 83,685 |
2 Oct 23 | ALIM Alimera Sciences | Stock Option Common Stock | Grant | Acquire A | No | No | 2.99 | 50,000 | 149.50 k | 50,000 |
15 Aug 23 | ALIM Alimera Sciences | Common Stock | Conversion | Acquire C | Yes | No | 1.7 | 4,178,725 | 7.10 mm | 4,178,725 |
15 Aug 23 | ALIM Alimera Sciences | Common Stock | Conversion | Acquire C | Yes | No | 2.1 | 2,924,762 | 6.14 mm | 9,429,808 |
15 Aug 23 | ALIM Alimera Sciences | Common Stock | Conversion | Acquire C | Yes | No | 1.7 | 4,845,392 | 8.24 mm | 6,505,046 |
15 Aug 23 | ALIM Alimera Sciences | Series B Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 2.1 | 6,000 | 12.60 k | 0 |
15 Aug 23 | ALIM Alimera Sciences | Series B Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 1.7 | 7,000 | 11.90 k | 0 |
15 Aug 23 | ALIM Alimera Sciences | Series B Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 1.7 | 8,117 | 13.80 k | 0 |